Related Experiment Video
Updated: May 5, 2026

12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.3K
Recombinant therapeutic protein vaccines
Satoshi Ohtake1, Tsutomu Arakawa
1Pfizer, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA. tarakawa2@aol.com.
Protein and Peptide Letters
|November 23, 2013
Summary
Recombinant technology enables scalable production of protein therapeutics and vaccines. This review details recombinant protein applications, focusing on viral and bacterial vaccines as alternatives to traditional ones.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Vaccinology
Background:
- Recombinant technology has revolutionized pharmaceutical production, enabling scalable and cost-effective generation of highly purified proteins.
- Protein therapeutics, including antibodies and plasma-derived products, are established treatments for various diseases.
- Advancements in expression, purification, and formulation have driven the development of these complex biologicals.
Purpose of the Study:
- To review the discovery and development of recombinant proteins like growth factors and cytokines.
- To provide an overview of monoclonal antibodies and enzyme replacement therapy.
- To focus on recombinant protein-based vaccines for viral and bacterial infections, evaluating their potential as replacements for existing vaccines.
Main Methods:
- Literature review of recombinant protein discovery and development.
- Analysis of advancements in protein expression, purification, and formulation technologies.
- Detailed examination of recombinant protein-based vaccines, including their application against viral and bacterial pathogens.
Main Results:
- Recombinant technology facilitates the production of therapeutic proteins and vaccines with high purity and scalability.
- Recombinant proteins have diverse applications, including growth factors, cytokines, monoclonal antibodies, and enzyme replacement therapies.
- Recombinant protein-based vaccines show promise for preventing viral and bacterial infections, offering potential alternatives to conventional vaccines.
Conclusions:
- Recombinant technology is a cornerstone of modern pharmaceutical development, offering versatile therapeutic and prophylactic solutions.
- Recombinant protein-based vaccines represent a significant advancement in vaccinology, with ongoing research addressing challenges for widespread adoption.
- The continued evolution of recombinant protein technology promises further innovation in treating diseases and preventing infections.
Related Concept Videos
Recombinant DNA
92.8K
Overview
92.8K
Recombinant DNA
17.5K
17.5K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines
104
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
104
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K

